PMA device
Medtronic(R) Synchromed(Tm) Pump & Infusion System
Medtronic, Inc. · Pump, Infusion, Implanted, Programmable (LKK, Class III) · First FDA decision Nov 10, 2008, newest Jan 31, 2018Chronic pain
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
6
Naming "Medtronic Synchromed"
MAUDE reports
34
Brand "Medtronic Synchromed", since 2015
PubMed studies
24
Mentioning "Medtronic Synchromed"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Medtronic(R) Synchromed(Tm) Pump & Infusion System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- MEDTRONIC(R) SYNCHROMED(TM) PUMP & INFUSION SYSTEMPMA supplement
P860004-S262 · Decided Jan 31, 2018 · 457 days after receipt · Normal 180 Day Track
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
- MEDTRONIC(R) SYNCHROMED(TM) PUMP & INFUSION SYSTEMPMA supplement
P860004-S246 · Decided Apr 21, 2016 · 73 days after receipt · Normal 180 Day Track
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
P860004-S090 · Decided Nov 10, 2008 · 507 days after receipt · Normal 180 Day Track
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Medtronic Synchromed", any status and sponsor, newest update first.
National Cancer Institute (NCI)NIH
NCT03366155 · 24 participants · Start Jun 24, 2019 · Primary completion Nov 13, 2025
Device: Codman 3000 constant flow pump catheter; Medtronic SynchroMed II Pump · For: Colorectal Cancer; Liver Metastases; Colorectal Adenocarcinoma and 2 more
Sites: Bethesda, Maryland
Wake Forest University Health SciencesAcademic, hospital or other
NCT05674240 · 30 participants · Start Dec 6, 2022 · Primary completion Mar 20, 2026
Device: Intrathecal Targeted Drug Delivery · For: Cancer Pain; Chronic Pain; Cancer Associated Pain and 1 more
Sites: Oshkosh, Wisconsin
- Infusion System for Hepatic CancerActive, not recruiting
Ronald DeMatteo, M.D.Academic, hospital or other
NCT04684862 · 100 participants (planned) · Start Feb 8, 2021 · Primary completion Jul 2029
Device: Medtronic SynchroMed II programmable pump connected to an Intera tapered catheter (Combined Infusion System) · For: Colorectal Cancer Metastatic to Liver; Intrahepatic Cholangiocarcinoma
Sites: Philadelphia, Pennsylvania
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Medtronic Synchromed", and for the whole product code for context.
This brand
34 reports: 5 malfunction, 24 injury, 4 death
Whole product code LKK
71,356 reports: 25,333 malfunction, 45,674 injury, 326 death
Newest reports for this brand
MW6004131 · Received Oct 16, 2026 · Event dated Jul 21, 2026
Device type: Pump, Infusion, Implanted, Programmable (LKK)
Device problem as coded: Infusion or Flow Problem; Data Problem
Patient problem as coded: Pain; Burning Sensation; Nervous System Injury; Bladder Dysfunction
MW5189094 · Received Jun 9, 2026 · Event dated Mar 19, 2026
Device type: Pump, Infusion, Implanted, Programmable (LKK)
Patient problem as coded: Abscess; Bacterial Infection; Cardiac Arrest; Purulent Discharge; Erythema; Perforation; Low Oxygen Saturation; Heart Failure/Congestive Heart Failure; Drug Resistant Bacterial Infection; Swelling/ Edema
- MEDTRONIC SYNCHROMED 3Injury
MW5168619 · Received Apr 4, 2025 · Event dated Mar 1, 2025
Device type: Pump, Infusion, Implanted, Programmable (LKK)
Device problem as coded: Product Quality Problem; Failure to Deliver; Application Program Version or Upgrade Problem
Patient problem as coded: Pain
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2201-2026 · Started Apr 8, 2026 · Posted by FDA May 14, 2026
Reason given: Software issue: When programming the SynchroMed Pump with the A810 CP App in Flex Infusion Mode, the infusion steps should automatically be arranged in consecutive order, from earliest to latest. However, in rare cases, the steps may be displayed out of order. If this occurs, the programmed Flex Infusion schedule will...
Cause as FDA categorized it: Under Investigation by firm · Device type: Pump, Infusion, Implanted, Programmable (LKK)
- A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System.Open, Classified
Z-1506-2025 · Started Jan 9, 2025 · Posted by FDA Apr 1, 2025
Reason given: Product complaints were received describing the A820 myPTM app taking longer than expected for patients to interact with their implantable pump.
Cause as FDA categorized it: Under Investigation by firm · Device type: Pump, Infusion, Implanted, Programmable (LKK)
- Medtronic Ascenda Intrathecal Catheter, Models: a) 8780 (114 cm); b) 8781 (140 cm); c) 8784 (catheter pump revision kit)Open, Classified
Z-2352-2024 · Started May 10, 2024 · Posted by FDA Jul 12, 2024
Reason given: Design update to the Ascenda Intrathecal Catheter Models 8780, 8781, and 8784. The intent of the design update is to reduce the potential for tissue growth into the Ascenda catheter connector which may potentially lead to catheter occlusion.
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Implanted, Programmable (LKK)
37 more recall records with a free account
Published research
The most relevant PubMed records for "Medtronic Synchromed"[tiab]. The summary above synthesizes these.
- Medtronic SynchroMed drug administration system.
Heruth KT · Ann N Y Acad Sci · 1988Clinical Trial
- [Adjuvant chemotherapy].
Del Nero A, Mandressi A, Longo G, et al. · Arch Ital Urol Nefrol Androl · 1991English Abstract
- Transcutaneous spinal stimulation in patients with intrathecal baclofen pump delivery system: A preliminary safety study.
Lopez J, Forrest GF, Engel-Haber E, et al. · Front Neurosci · 2022
- Malfunction of SynchroMed II baclofen pump delivers a near-lethal baclofen overdose.
Sgouros S, Charalambides C, Matsota P, et al. · Pediatr Neurosurg · 2010Case Reports
- Intrathecal Pump: An Abrupt Intermittent Pump Failure.
Riordan J, Murphy P · Neuromodulation · 2015Case Reports
- Effect of intrathecal baclofen concentration on spasticity control: case series.
Saval A, Chiodo AE · J Spinal Cord Med · 2008Case Reports
- A programmable and implantable pumping system for systemic chemotherapy: a performance analysis in 52 patients.
Vogelzang NJ, Ruane M, Ratain MJ, et al. · J Clin Oncol · 1987Clinical Trial, Research Support, Non-U.S. Gov't
- Sudden Intrathecal Drug Delivery Device Motor Stalls: A Case Series.
Galica R, Hayek SM, Veizi IE, et al. · Reg Anesth Pain Med · 2016Research Support, Non-U.S. Gov't
- Solubility and Stability of Baclofen 3 mg/mL Intrathecal Formulation and Its Compatibility With Implantable Programmable Intrathecal Infusion Systems.
Yue B, Brendel R, Lukitsch A, et al. · Neuromodulation · 2017
- Phase I Safety and Feasibility Pilot of Hepatic Artery Infusion Chemotherapy in a Rural Catchment Area Using The Codman Vascular Catheter with The Medtronic SynchroMed II Pump for Intrahepatic Cancers.
McDonald HG, Zaki OA, Wright MJ, et al. · Ann Surg Oncol · 2024
- Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pump.
Sonabend AM, Stuart RM, Yun J, et al. · Neuro Oncol · 2011Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Chemical stability of ziconotide-clonidine hydrochloride admixtures with and without morphine sulfate during simulated intrathecal administration.
Shields D, Montenegro R · Neuromodulation · 2007
Other devices of this type
Also filed under product code LKK.
- SynchroMed Infusion System, Ascenda Intrathecal CathetersMedtronic, Inc. · PMA 2026
- Prometra Programmable Infusion Pump SystemInfusyn Therapeutics, LLC · PMA 2025
- Synchromed II Pump RemediationMedtronic, Inc. · PMA 2017
- Implantable System for RemodulinMedtronic, Inc. · PMA 2021
- Medstream Programmable Infusion SystemIntera Oncology · PMA 2014
- IsoMed Infusion SystemMedtronic, Inc. · PMA 2023
- INFUSAID Implantable Infusion Pump and AccessoriesIntera Oncology · PMA 2020
- 3000 Series Implantable Infusion Pump and the MedStream Programmable Infusion System and AccessoriesIntera Oncology · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.